Novartis AG
1,2,4-oxadiazole derivatives as liver X receptor agonists

Abstract:

Provided herein are compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or a compound of Formula (I'), or pharmaceutical composition described herein. ##STR00001##